Pharmacogenomics is the study of how a patient's genes could affect their response to a drug; it is a way to personalize medicine and prescribe the optimal drug at the most advantageous dose for that patient, instead of a one drug fits all or trial and error theme. In the future doctors could predict who would respond to a drug and who would experience adverse reactions. Even with our advances in medicine, not every patient will have a full response to every drug. Pharmacogenomics could help identify which patients would not benefit from a drug and avoid adverse effects potentially leading to toxicity and death. Overall, pharmacogenomics could lead to the selection of the most effective, safe medicine at accurate dosing regimens, which would potentially decrease health care costs dramatically.
CD Genomics' pharmacogenomics panels are predesigned panels for targeted sequencing of genes and mutations associated with multiple diseases and drugs. Targeted NGS sequencing facilitates sequencing of a large number of genes and samples in a single and cost-effective assay.